<DOC>
	<DOCNO>NCT00722410</DOCNO>
	<brief_summary>Infection Klebsiella pneumonia produce class A carbapenemases major clinical public health problem Israel worldwide . The aim study determine safety efficacy alteration gut microflora probiotic , alone combination mechanical bowel cleansing , strategy eradicate colonization gastrointestinal tract CRKP . We hypothesize administration probiotic decrease rate GI colonization CRKP .</brief_summary>
	<brief_title>Probiotics Eradication Carbapenem Resistant Klebsiella Pneumonia</brief_title>
	<detailed_description>CRKP colonization determine culture PCR rectal swab . The study include 3 arm - intervention , probiotic mechanical bowel cleanse + probiotic . Followup examination rectal swab sample presence CRKP perform 4 week 12 week study entry .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Klebsiella Infections</mesh_term>
	<criteria>1 . Subjects &gt; 18 year age . 2 . Signing informed consent subject legal custodian . 3 . Colonization gastrointestinal tract CRKP determine stool culture PCR stool blakpc gene . 4 . Negative culture CRKP extraintestinal site exclude urine . 1 . Subjects participate another clinical trial within last three month . 2 . Women childbearing potential unless use adequate contraception ( IUD , oral depot contraceptive barrier plus spermicide ) . 3 . Subjects pregnant breast feeding . 4 . Subjects unavailable duration trial , likely noncompliant protocol , felt unsuitable investigator reason . 5 . Subjects chronic diarrhea ( &gt; 4 week ) . 6 . Subjects inflammatory bowel disease . 7 . Subjects whose stool positive Clostridium difficile toxin . 8 . Subjects receive immunosuppressive treatment ( i.e . corticosteroid ; azathioprine 6MP ; cyclosporine ; tacrolimus ; OKT3 , methotrexate ; anti TNF agent ; chemotherapy ) . 9 . Subjects underwent solid organ hematopoietic stem cell transplantation . 10 . Subjects primary secondary immunodeficiency disorder , include HIV . 11 . Subjects chronic advanced cardiac , respiratory , renal liver disease . 12 . Subjects advance malignant disease . 13 . Subjects severe acute organ failure . 14 . Subjects CRKP isolate site stool urine ( i.e . blood , sputum wound culture ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Carbapenem</keyword>
	<keyword>resistant</keyword>
	<keyword>Klebsiella pneumoniae</keyword>
	<keyword>Carpapenemases</keyword>
	<keyword>Probiotics</keyword>
	<keyword>VSL3</keyword>
</DOC>